Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer
- PMID: 16230372
- DOI: 10.1158/0008-5472.CAN-05-2553
Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer
Abstract
Microarray analysis has been shown to improve risk stratification of breast cancer. Breast tumors analyzed by hierarchical clustering of expression patterns of "intrinsic" genes have been reported to subdivide into at least four molecular subtypes that are associated with distinct patient outcomes. Using a supervised method, a 70-gene expression profile has been identified that predicts the later appearance or absence of clinical metastasis in young breast cancer patients. Here, we show that distant metastases display both the same molecular breast cancer subtype as well as the 70-gene prognosis signature as their primary tumors. Our results suggest that the capacity to metastasize is an inherent feature of most breast cancers. Furthermore, our data imply that poor prognosis breast carcinomas classified either by the intrinsic gene set or the 70 prognosis genes represent distinct disease entities that seem sustained throughout the metastatic process.
Similar articles
-
A six-gene signature predicting breast cancer lung metastasis.Cancer Res. 2008 Aug 1;68(15):6092-9. doi: 10.1158/0008-5472.CAN-08-0436. Cancer Res. 2008. PMID: 18676831
-
[Prognostic molecular classification of breast cancers based on gene expression profiling].Zhonghua Zhong Liu Za Zhi. 2006 Dec;28(12):900-6. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17533740 Chinese.
-
Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients.Breast Cancer Res Treat. 2007 Jul;103(3):319-29. doi: 10.1007/s10549-006-9385-7. Epub 2006 Nov 23. Breast Cancer Res Treat. 2007. PMID: 17123152
-
[Gene expression profiling of ER+ breast cancers: to discriminate the poor prognosis tumors or to define the most suitable treatment?].Bull Cancer. 2008 May;95(5):513-8. doi: 10.1684/bdc.2008.0646. Bull Cancer. 2008. PMID: 18541515 Review. French.
-
Micrometastasis in breast cancer and other solid tumors.J Biol Regul Homeost Agents. 2004 Apr-Jun;18(2):120-5. J Biol Regul Homeost Agents. 2004. PMID: 15471214 Review.
Cited by
-
Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design.Int J Mol Sci. 2012;13(2):1951-2011. doi: 10.3390/ijms13021951. Epub 2012 Feb 13. Int J Mol Sci. 2012. PMID: 22408433 Free PMC article. Review.
-
Molecular portrait-based correlation between primary canine mammary tumor and its lymph node metastasis: possible prognostic-predictive models and/or stronghold for specific treatments?BMC Vet Res. 2012 Nov 12;8:219. doi: 10.1186/1746-6148-8-219. BMC Vet Res. 2012. PMID: 23146872 Free PMC article.
-
Gene arrays for diagnosis, prognosis and treatment of breast cancer metastasis.Clin Exp Metastasis. 2007;24(8):575-85. doi: 10.1007/s10585-007-9110-x. Epub 2007 Nov 1. Clin Exp Metastasis. 2007. PMID: 17973194 Review.
-
p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer.Cancer Cell. 2013 Sep 9;24(3):318-30. doi: 10.1016/j.ccr.2013.08.013. Cancer Cell. 2013. PMID: 24029231 Free PMC article.
-
An integrative genomics approach to biomarker discovery in breast cancer.Cancer Inform. 2011;10:185-204. doi: 10.4137/CIN.S6837. Epub 2011 Jul 25. Cancer Inform. 2011. PMID: 21869864 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases